GSPT1 targeting therapy (Degron Therapeutics Co Ltd)

N/A

Report date: 2025/11/25 11:44:06

Base Information

Drug NameGSPT1 targeting therapy (Degron Therapeutics Co Ltd)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate
Mechanisms of ActionEukaryotic peptide chain release factor GTP-binding subunit ERF3A degraders
TargetsEukaryotic peptide chain release factor GTP-binding subunit ERF3A
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesDegron Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDegron Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A